Themis Medicare Ltd (THEMISMED):企業の財務・戦略的SWOT分析

◆英語タイトル:Themis Medicare Ltd (THEMISMED) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14757
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Themis Medicare Ltd (Themis Medicare), a subsidiary of Gedeon Richter Plc is a differentiated injectables developer that manufactures and markets pharmaceutical and healthcare products. The company’s products include formulations, original products, active pharmaceutical ingredients and dietary supplements, among others. It also provides sepgard gels, solutions, emal injection and mouth gargle. Themis Medicare develops active pharmaceutical ingredients and formulations in therapeutic areas of anti-infectives, cardiology, pain management, antimalarials, cholesterol, haematinics, neutraceutical, antituberculosis, health and nutrition, among others. The company offers dietary supplements for kids and adults; new drug delivery systems such as tablets, injections and gel. It has its operations in Hyderabad, Valsad, Telangana and Haridwar, India. Themis Medicare is headquartered in Mumbai, Maharashtra, India.

Themis Medicare Ltd Key Recent Developments

Aug 22,2018: Themis Medicare: European Union – Good Manufacturinq Practice (EU-GMP) – Certification
Jul 12,2018: Themis Medicare Receives Letter from USFDA

This comprehensive SWOT profile of Themis Medicare Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Themis Medicare Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Themis Medicare Ltd – Key Information
Themis Medicare Ltd – Overview
Themis Medicare Ltd – Key Employees
Themis Medicare Ltd – Key Employee Biographies
Themis Medicare Ltd – Key Operational Heads
Themis Medicare Ltd – Major Products and Services
Themis Medicare Ltd – History
Themis Medicare Ltd – Company Statement
Themis Medicare Ltd – Locations And Subsidiaries
Themis Medicare Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Themis Medicare Ltd – Business Description
Themis Medicare Ltd – Corporate Strategy
Themis Medicare Ltd – SWOT Analysis
SWOT Analysis – Overview
Themis Medicare Ltd – Strengths
Themis Medicare Ltd – Weaknesses
Themis Medicare Ltd – Opportunities
Themis Medicare Ltd – Threats
Themis Medicare Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Themis Medicare Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Themis Medicare Ltd, Key Information
Themis Medicare Ltd, Key Ratios
Themis Medicare Ltd, Share Data
Themis Medicare Ltd, Major Products and Services
Themis Medicare Ltd, History
Themis Medicare Ltd, Key Employees
Themis Medicare Ltd, Key Employee Biographies
Themis Medicare Ltd, Key Operational Heads
Themis Medicare Ltd, Other Locations
Themis Medicare Ltd, Subsidiaries
Themis Medicare Ltd, Key Manufacturing facilities
Themis Medicare Ltd, Key Competitors
Themis Medicare Ltd, SWOT Analysis
Themis Medicare Ltd, Ratios based on current share price
Themis Medicare Ltd, Annual Ratios
Themis Medicare Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Themis Medicare Ltd, Performance Chart
Themis Medicare Ltd, Ratio Charts

★海外企業調査レポート[Themis Medicare Ltd (THEMISMED):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gilead Sciences, Inc.:戦略・SWOT・企業財務分析
    Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Zebra Technologies Corp (ZBRA):企業の財務・戦略的SWOT分析
    Zebra Technologies Corp (ZBRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Winbond Electronics Corporation (2344):企業の財務・戦略的SWOT分析
    Winbond Electronics Corporation (2344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Jack Chia Industries (Thailand) Public Company Ltd (JCT):企業の財務・戦略的SWOT分析
    Jack Chia Industries (Thailand) Public Company Ltd (JCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Guangzhou Wondfo Biotech Co Ltd (300482)-医療機器分野:企業M&A・提携分析
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that provides rapid diagnostic services. The company manufactures medical products and biochemical reagents. Its products include rapid test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo a …
  • Ablynx NV (ABLX)-製薬・医療分野:企業M&A・提携分析
    Summary Ablynx NV (Ablynx) is a clinical-stage biopharmaceutical company focused on the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional …
  • The Kansai Electric Power Co Inc (9503):電力:M&Aディール及び事業提携情報
    Summary The Kansai Electric Power Co Inc (KEPCo) is an integrated power utility. It produces and supplies electricity and thermal energy; and procures and sells natural gas. The company generates electricity using natural gas, nuclear, coal, oil, wind, hydro, and solar sources. Through long, medium, …
  • Oncolix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Oncolix Inc (Oncolix) is a clinical stage biopharmaceutical company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant analogue to the human prolactin and acts as an antagonist to the prolactin receptor …
  • Toppan Forms Co., Ltd.:企業の戦略・SWOT・財務情報
    Toppan Forms Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Norsk Hydro ASA:戦略・SWOT・企業財務分析
    Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report Summary Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • Pyxus International Inc:企業の戦略・SWOT・財務情報
    Pyxus International Inc - Strategy, SWOT and Corporate Finance Report Summary Pyxus International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HeartSine Technologies LLC:企業の戦略的SWOT分析
    HeartSine Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • International AIDS Vaccine Initiative-製薬・医療分野:企業M&A・提携分析
    Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also …
  • Viavi Solutions Inc:企業の戦略・SWOT・財務分析
    Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cap Gemini S.A.:戦略・SWOT・企業財務分析
    Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report Summary Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Canadian Cancer Trials Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Canadian Cancer Trials Group (CCTG), is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The company conducts trials for the development of new drugs and therapies for the treatment of various diseases. It pro …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務情報
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆